H-1B sponsorship profile: Amneal Pharmaceuticals of New York. Across U.S. Department of Labor LCA disclosures, Amneal Pharmaceuticals of New York filed 27 Labor Condition Applications covering 27 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (27 certified of 27 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Amneal Pharmaceuticals of New York’s H-1B petitions range from $67,383 at the low end to $241,272 at the high end, with a petition-weighted average of $123,394. That range reflects the mix of occupations the company sponsors, led by Associate Scientist, Quality Control (3 petitions at $71,809 avg), followed by Scientist, Quality Control and Facility Engineer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Amneal Pharmaceuticals of New York is headquartered in Brookhaven, NY under NAICS code 32541, and places H-1B workers across 1 state, most heavily in NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Amneal Pharmaceuticals of New York ranks. By H-1B petition volume, Amneal Pharmaceuticals of New York is #8,004 of 119,880 employers nationally and #628 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.